• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆瘦素水平与未来静脉血栓栓塞事件风险。

Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.

机构信息

Department of Clinical Medicine, Thrombosis Research Center, UiT - The Arctic University of Norway, Tromsø, Norway.

Faculty of Medicine, University of Oslo, Oslo, Norway.

出版信息

Thromb Haemost. 2022 Apr;122(4):560-569. doi: 10.1055/s-0041-1732295. Epub 2021 Jul 11.

DOI:10.1055/s-0041-1732295
PMID:34264516
Abstract

BACKGROUND

Circulating levels of leptin, an adipocyte-derived hormone, are frequently elevated in obesity. Leptin has been reported to upregulate prothrombotic hemostatic factors in vitro and could potentially mediate venous thromboembolism (VTE) risk in obesity. However, whether leptin is associated with VTE remains uncertain.

OBJECTIVE

This article investigates the association between plasma leptin and risk of incident VTE, and the potential of leptin to mediate VTE risk in obesity.

METHODS

A population-based nested case-control study with 416 VTE cases and 848 age- and sex-matched controls was derived from the Tromsø Study. Logistic regression was used to calculate odds ratios (ORs) with 95% confidence intervals (CIs) for VTE across leptin quartiles. Analyses were performed separately in men and women using sex-specific quartile cut-offs determined in controls.

RESULTS

In the age-adjusted model, the VTE risk increased across leptin quartiles, particularly in men. Compared with the lowest quartile, the ORs for VTE in the highest quartile were 1.70 (95% CI 1.04-2.79) in men and 1.36 (95% CI 0.85-2.17) in women. However, with additional adjustment for body mass index (BMI), risk estimates were markedly attenuated in men (OR 1.03, 95% CI 0.55-1.93) and women (OR 0.82, 95% CI 0.45-1.48). The ORs for VTE were increased in obese men and women (BMI ≥ 30 kg/m) and were only marginally affected after adjustment for leptin.

CONCLUSION

Our results indicate that the apparent association between plasma leptin levels and VTE risk is confounded by BMI and that leptin is not a relevant mediator for VTE risk in obesity.

摘要

背景

循环中瘦素水平,一种脂肪细胞衍生的激素,在肥胖症中经常升高。有报道称,瘦素可体外上调促血栓形成的止血因子,并可能介导肥胖症中的静脉血栓栓塞(VTE)风险。然而,瘦素是否与 VTE 相关仍不确定。

目的

本研究旨在探讨血浆瘦素与 VTE 发病风险的关系,以及瘦素在肥胖症中对 VTE 风险的潜在介导作用。

方法

本研究采用基于人群的巢式病例对照研究,416 例 VTE 患者和 848 例年龄和性别匹配的对照者来自特罗姆瑟研究。使用逻辑回归计算 VTE 在瘦素四分位区间的比值比(OR)及其 95%置信区间(CI)。使用在对照组中确定的性别特异性四分位位值,分别在男性和女性中进行分析。

结果

在年龄调整模型中,VTE 风险随瘦素四分位区间的升高而增加,尤其是在男性中。与最低四分位区间相比,最高四分位区间男性的 VTE OR 为 1.70(95%CI 1.04-2.79),女性为 1.36(95%CI 0.85-2.17)。然而,在进一步调整体重指数(BMI)后,男性(OR 1.03,95%CI 0.55-1.93)和女性(OR 0.82,95%CI 0.45-1.48)的风险估计值明显减弱。在肥胖的男性和女性(BMI≥30kg/m)中,VTE 的 OR 增加,并且在调整瘦素后仅略有影响。

结论

我们的结果表明,血浆瘦素水平与 VTE 风险之间的明显关联受 BMI 混杂,并且瘦素不是肥胖症中 VTE 风险的相关介导物。

相似文献

1
Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.血浆瘦素水平与未来静脉血栓栓塞事件风险。
Thromb Haemost. 2022 Apr;122(4):560-569. doi: 10.1055/s-0041-1732295. Epub 2021 Jul 11.
2
Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.血浆纤溶酶原激活物抑制剂-1 水平升高与未来发生静脉血栓栓塞的风险相关。
J Thromb Haemost. 2022 Jul;20(7):1618-1626. doi: 10.1111/jth.15701. Epub 2022 Mar 25.
3
Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.血浆 D-二聚体水平升高与未来发生静脉血栓栓塞的风险相关。
Thromb Res. 2021 Dec;208:121-126. doi: 10.1016/j.thromres.2021.10.020. Epub 2021 Oct 26.
4
Plasma levels of P-selectin and future risk of incident venous thromboembolism.血浆 P 选择素水平与静脉血栓栓塞事件的未来风险。
J Thromb Haemost. 2023 Sep;21(9):2451-2460. doi: 10.1016/j.jtha.2023.04.038. Epub 2023 May 12.
5
Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism.生长分化因子 15 的血浆水平与静脉血栓栓塞的未来风险相关。
Blood. 2020 Oct 15;136(16):1863-1870. doi: 10.1182/blood.2019004572.
6
Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolism.血小板衍生微泡的血浆水平与未来发生静脉血栓栓塞的风险相关。
J Thromb Haemost. 2022 Apr;20(4):899-908. doi: 10.1111/jth.15638. Epub 2022 Jan 19.
7
Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.血浆血管性血友病因子水平与静脉血栓栓塞症的未来风险。
Blood Adv. 2021 Jan 12;5(1):224-232. doi: 10.1182/bloodadvances.2020003135.
8
Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism.通过血浆末端补体复合物评估补体激活与静脉血栓栓塞的未来风险。
J Thromb Haemost. 2019 Jun;17(6):934-943. doi: 10.1111/jth.14438. Epub 2019 May 13.
9
Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism.血管性血友病因子-ADAMTS13 轴对未来静脉血栓栓塞风险的影响。
J Thromb Haemost. 2023 May;21(5):1227-1237. doi: 10.1016/j.jtha.2023.01.024. Epub 2023 Feb 1.
10
The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study.超重和肥胖与静脉血栓栓塞事件风险的关系:特罗姆瑟研究。
Thromb Haemost. 2024 Mar;124(3):239-249. doi: 10.1055/s-0043-1772212. Epub 2023 Aug 7.

引用本文的文献

1
Venous thrombosis unchained: Pandora's box of noninflammatory mechanisms.静脉血栓形成的非束缚状态:非炎症机制的潘多拉魔盒。
Blood Adv. 2025 Jun 24;9(12):3002-3013. doi: 10.1182/bloodadvances.2024014114.
2
Circulating adipokine concentrations and the risk of venous thromboembolism: A Mendelian randomization and mediation analysis.循环脂肪因子浓度与静脉血栓栓塞风险:孟德尔随机化与中介分析
Front Genet. 2023 Mar 28;14:1113111. doi: 10.3389/fgene.2023.1113111. eCollection 2023.
3
Adipokines and incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis.
脂肪细胞因子与静脉血栓栓塞症事件:动脉粥样硬化的多种族研究。
J Thromb Haemost. 2023 Feb;21(2):303-310. doi: 10.1016/j.jtha.2022.11.012. Epub 2022 Dec 22.
4
Circulating Adipokines and Associations With Incident Cardiovascular Disease in Rheumatoid Arthritis.循环脂肪因子与类风湿关节炎患者心血管疾病发病的相关性。
Arthritis Care Res (Hoboken). 2023 Apr;75(4):768-777. doi: 10.1002/acr.24885. Epub 2022 Nov 11.
5
Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.血浆纤溶酶原激活物抑制剂-1 水平升高与未来发生静脉血栓栓塞的风险相关。
J Thromb Haemost. 2022 Jul;20(7):1618-1626. doi: 10.1111/jth.15701. Epub 2022 Mar 25.